Cargando…
Sulforaphane Represses Matrix-Degrading Proteases and Protects Cartilage From Destruction In Vitro and In Vivo
OBJECTIVE: Sulforaphane (SFN) has been reported to regulate signaling pathways relevant to chronic diseases. The aim of this study was to investigate the impact of SFN treatment on signaling pathways in chondrocytes and to determine whether sulforaphane could block cartilage destruction in osteoarth...
Autores principales: | Davidson, Rose K, Jupp, Orla, de Ferrars, Rachel, Kay, Colin D, Culley, Kirsty L, Norton, Rosemary, Driscoll, Clare, Vincent, Tonia L, Donell, Simon T, Bao, Yongping, Clark, Ian M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240673/ https://www.ncbi.nlm.nih.gov/pubmed/23983046 http://dx.doi.org/10.1002/art.38133 |
Ejemplares similares
-
The role of AGEs in pathogenesis of cartilage destruction in osteoarthritis
por: He, Chao-Peng, et al.
Publicado: (2022) -
Generation of human immortalized chondrocytes from osteoarthritic and healthy cartilage: a new tool for cartilage pathophysiology studies
por: Piñeiro-Ramil, María, et al.
Publicado: (2023) -
Whole-transcriptome sequencing of knee joint cartilage from osteoarthritis patients
por: Li, H., et al.
Publicado: (2019) -
Regeneration of injured articular cartilage using the recombinant human amelogenin protein
por: Helwa-Shalom, Omer, et al.
Publicado: (2023) -
Molecular crosstalk between articular cartilage, meniscus, synovium, and subchondral bone in osteoarthritis
por: Wang, Maochun, et al.
Publicado: (2022)